subject area of
- A randomized trial of Pegaptanib sodium for age-related macular degeneration used an innovative design to explore disease-modifying effects Journal Articles
- ASCEND-Eye Journal Articles
- Age-related macular degeneration Journal Articles
- Age-related macular degeneration: is polypoidal choroidal vasculopathy recognized and treated? Journal Articles
- Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis Journal Articles
- Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis Journal Articles
- Antioxidants and vision health: facts and fiction Journal Articles
- Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group. Journal Articles
- Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study Journal Articles
- Cell‐adhesive thermogelling PNIPAAm/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics Journal Articles
- Diagnostic accuracy of teleretinal screening for detection of diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysis Journal Articles
- Discrepancies in physician–patient agreement in reporting ocular history Journal Articles
- Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 Journal Articles
- IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Journal Articles
- Imaging Biomarkers and Their Impact on Therapeutic Decision-Making in the Management of Neovascular Age-Related Macular Degeneration Journal Articles
- Maculopathie causée par le polysulfate de pentosan Journal Articles
- Maculopathy caused by pentosan polysulfate Journal Articles
- Measuring atrophy in age-related macular degeneration: why does reliability matter? Journal Articles
- PIGMENT EPITHELIAL DETACHMENT THICKNESS AND VARIABILITY AFFECTS VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Journal Articles
- Paracentral acute middle maculopathy after meningococcal vaccination in a young female Journal Articles
- Power function arguments in support of an alternative approach for analyzing management trials Journal Articles
- Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration Journal Articles
- Rapid Expansion of Intravitreal Drug Injection Procedures, 2000 to 2008 Journal Articles
- Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis Journal Articles
- The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis Journal Articles
- The physics, biophysics and technology of photodynamic therapy Journal Articles
- The treatment of wet AMD in Canada: access to therapy (policy review) Journal Articles
- Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? Journal Articles
- Treatment of geographic atrophy: an update on data related to pegcetacoplan Journal Articles
- Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study Journal Articles
- Triamcinolone Acetonide as Adjunctive Treatment to Verteporfin in Neovascular Age-Related Macular Degeneration Journal Articles
- Waiting room educational media effect on preinjection anxiety for initial intravitreal injections Journal Articles
- [Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration]. Journal Articles